DMAC Stock Earnings: DiaMedica Therapeutics Beats EPS for Q2 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

DMAC stock results show that DiaMedica Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.

The post DMAC Stock Earnings: DiaMedica Therapeutics Beats EPS for Q2 2024 appeared first on InvestorPlace.

• Legendary Investor Predicts: “Forget AI... THIS Technology Is the Future”